Entries by Phil Case

Anpac Bio Wins Global Precision Medicine Industry Award: 2017 ‘Most Promising Cancer Screening Company’

SACRAMENTO, Calif., July 17, 2017 —The Global Precision Medicine Industry Awards leadership named international life sciences corporation Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio”), the 2017, “Most Promising Cancer Screening Company” award winner; in recognition of Anpac Bio’s proprietary, “Cancer Differentiation Analysis” (CDA) liquid biopsy cancer screening and diagnostic support services. Citing Anpac Bio’s, “excellence in diagnostics services”, the Global Precision Medicine Industry […]

Anpac Bio Surpasses 40,000 Case Study Milestone ‘Liquid Biopsy Pioneer’ Serving Individual, Medical, Insurance & Corporate Customers.

SACRAMENTO, Calif., March 28, 2017 /PRNewswire/ — Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, announced this week the company set a new, international record, processing and reporting over 40,000 cases worldwide of the company’s proprietary, “Cancer Differentiation Analysis” (CDA) liquid biopsy tests. Described as “game changing”, in […]

Anpac Bio proud to sponsor the inaugural ‘Anpac Bio World Youth Innovation Forum’, at 2016 World Nobel Prize Laureate Summit, featuring the theme”Serendipity in Science”

Seven Nobel Prize Laureates and over 20 internationally acclaimed researchers and scientists, are presenting at the third annual, “World Nobel Prize Laureate Summit“ in Chengdu, China, September 2-3, 2016. The 2016 WNPLS’ will feature three programs of scientific exploration: 1) “Anpac Bio World Youth Innovation Forum“; 2) “International Symposium for Precision Medicine“; and 3) the […]

Anpac Bio CEO Keynote Speaker at UC Biomedical & Engineering Entrepreneurship Academy

SACRAMENTO, Calif., July 8, 2016  — Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, will deliver the Keynote Address to award-winning life and technical science students, faculty, administration, corporate partners, officials, and general public, to launch the University of California Biomedical & Engineering Entrepreneurship Academy (BMEA), Monday, July 11, […]

Anpac Bio-Medical Science Pledges $50,000 to UC Davis ChildFamily Institute for innovation and Entrepreneurship

Anpac Fellowships Underwrite University of California Students to Attend Scientific Innovation Academies SACRAMENTO, Calif., Jan. 7, 2016 — Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, has pledged $50,000 to the University of California, Davis Child Family Institute for Innovation and Entrepreneurship (UCDCFIIE) to underwrite student fellowships and support […]

Anpac Bio-Medical Presenting ‘Breakthrough’ Cancer Screening Tech/Research At Breast Cancer Symposium

SACRAMENTO, Calif., Sept. 16, 2015 — Anpac Bio-Medical Science Company Chief Executive Officer Dr. Chris Yu and Anpac scientists will be presenting “breakthrough,” Breast Cancer screening and early detection research results at the upcoming “Breast Cancer Symposium” in San Francisco, California, September 25-27, 2015. Reporting outcomes generated through Anpac’s novel, non-invasive, “Cancer Differentiation Analysis” (CDA) […]

©2021 Anpac Bio-Medical Science Co., Ltd.